Flash Webinar - 30 minutes to identify public funding for your healthcare, biotech and MedTech projects
Against a backdrop of reindustrialization of the healthcare sector and accelerating medical innovation, identifying the public financing that can be activated in 2026 becomes a major strategic challenge for companies in the sector. Biotechnologies, biomanufacturing, innovative medical devices, digital healthcare solutions, new therapies, pharmaceutical industrialization: a wide range of national and European funding windows support these projects.
This resource provides you with a synthetic, operational and directly usable vision financing options for your healthcare innovation projects.
Health, BioTech and MedTech: what financing will be needed in 2026?
Discover the support available for the healthcare sector
Ask the experts your questions when you register.
Why view this webinar on public healthcare subsidies?
Healthcare projects are long, capital-intensive and highly regulated. However, there are a number of ways in which they can be co-financed:
- The R&D in health and biotechnologies
- The bioproduction and industrialization of innovative therapies
- The development of medical devices (DM) and MedTech
- Solutions from e-health and digital health
- National and European collaborative projects
It's also important to understand public priorities, eligibility criteria and expected strategic positioning.
In just 30 minutes, we'll give you a clear picture of the 2026 opportunities to secure your financing.
Financing solutions for your healthcare, biotech and MedTech projects
We decipher :
- The national support for healthcare innovation and reindustrialization
- European opportunities via Horizon Europe (Health Cluster), Eurostars and health acceleration programs
- The levels of funding available, aid intensities and key eligibility criteria
- The good practices to build a solid, competitive business case
This webinar replay aims to help you quickly assess whether your healthcare R&D or industrialization project can be supported in 2026.
Who is this resource for?
This webinar is aimed at players in the healthcare sector - startups, biotech and MedTech SMEs - as well as R&D, industrial, regulatory, financial and innovation departments involved in structuring projects.
It is particularly relevant for companies developing :
- Of new therapies and biotherapies
- Of innovative medical devices
- Solutions for digital health
- Industrialization or first plant projects
Whether you're new to public funding or already involved in the financing process, this session will give you a strategic overview.
Ready to quickly assess whether your project can be supported?
Your speaker
An expert in public funding of innovation
Fabienne DE TONI-COSTES, Senior Public Finance Consultant, G.A.C Group
With a doctorate in biology and a specialization in the valorization of research and biomedical innovation (UPS Toulouse - UPMC Paris), Fabienne has been helping players in the healthcare, biotech and pharma sectors to structure and finance their innovation projects for over 15 years. She works on complex R&D, biomanufacturing, medical device and new therapy projects, mobilizing the most appropriate national and European mechanisms. With over 250 projects completed and more than €50 million in public funding mobilized, we provide our customers with recognized expertise to secure their financing strategies and accelerate their development.
